N/A
N=77
Vitamin D Supplementation on Cardiovascular Risk Factors
Type 2 Diabetes
Bottom Line
View on ClinicalTrials.gov: NCT01412710 ↗Enrolled (actual)
77
Serious AEs
0.0%
Results posted
Dec 2017
Primary outcome: Primary: Blood Lipid — 213.08; 193.88 mg/dl
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Cholecalciferol (Drug)
- Age
- Adult, Older Adult · 30+ yrs
- Sex
- All
- Sponsor
- Florida International University
- Primary completion
- Sep 2013
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Blood Lipid |
213.08; 193.88 | — |
| SECONDARY Glycemic Control |
8.25; 8.26 | — |
Summary
The purpose of the present pilot study is to determine the effect of vitamin D supplementation (4000 IU or 6000 IU once daily for 6 months) on reducing heart disease risk and in improving blood glucose control in type 2 Diabetes subjects . The investigators are working with Hispanics and African Americans living in Miami, Florida.
Eligibility Criteria
Inclusion Criteria
- Type 2 diabetes
- African American or Hispanic
- able to ambulate on their own
- aged between 30 - 70 years
Exclusion Criteria
- Taking Supplemental Vitamin D
- Pregnant or Lactating women
- Receiving insulin therapy
- Not participating in other drug trials
- HIV/ hepatitis/ cancer/ liver disease/ heart failure/ any recent surgery/ mental illness/ epilepsy/ any GI or malabsorption disorders
- Kidney failure or on dialysis
Data sourced from ClinicalTrials.gov (NCT01412710). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.